Intelligence · Clinical Development
Pipeline search results
Programs matching “cyclophosphamide” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 29 pipeline programs matching "cyclophosphamide" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
APHP200026
Pari Pharma GmbH
Patients with GPA and inadequate response to standard of care therapy defined as an inadequate response to either a combination of glucocorticoids plus cyclophosphamide AND/OR a combination of glucocorticoids plus rituximab.
1 trial -
CYCLOPHOSPHAMIDE
Pari Pharma GmbH
The study will involve adult women and men from 16 French centers who have hematological malignancies and are candidates for haploidentical HSCT
1 trial -
Cyclophosphamide
Children's Hospital of Fudan University
Stage III Kidney Wilms Tumor
1 trial -
cyclophosphamide
Partner Therapeutics Limited
Breast Cancer
1 trial -
BDH-CLL-002-2022/02/14
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Lymphocytic Leukemia
1 trial -
CYCLOPHOSPHAMIDE for Inoperable locally advanced or…
Istituto Gentili S.r.l.
Inoperable locally advanced or metastatic TNBC patients, previously treated with anti-PD-L1/PD1- regimens
1 trial -
Cyclophosphamide
Iovance Biotherapeutics B.V.
Metastatic Bladder Urothelial Carcinoma
1 trial -
Cyclophosphamide
Takeda
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
1 trial -
Cyclophosphamide
Takeda
Multiple Myeloma
1 trial -
Cyclophosphamide
BEONE MEDICINES AUS PTY LTD
Recurrent Transformed Chronic Lymphocytic Leukemia
1 trial -
Cyclophosphamide
United Therapeutics Europe Ltd
Metastatic Melanoma
1 trial -
Cyclophosphamide
Iovance Biotherapeutics B.V.
Clinical Stage IV Cutaneous Melanoma AJCC v8
1 trial -
Cyclophosphamide
Karyopharm Therapeutics Inc
Myeloma Multiple
1 trial -
Cyclophosphamide
ADC Therapeutics SA
Double-Expressor Lymphoma
1 trial -
Cyclophosphamide
The First People's Hospital of Lianyungang
Acute Lymphoblastic Leukemia, Pediatric
1 trial -
Cyclophosphamide Doxorubicin Vincristine Lamivudine
Taiwan Liposome Company
Non-Hodgkin's Lymphoma
1 trial -
Cyclophosphamide+Pemetrexed+5-Fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Thyroid Gland Carcinoma
1 trial -
cyclophosphamide
Ultragenyx UK Limited
Pemphigus
1 trial -
cyclophosphamide
Ultragenyx UK Limited
Anemia, Hemolytic, Autoimmune
1 trial -
rituximab /Dexamethasone/cyclophosphamide
The First People's Hospital of Lianyungang
Treatment
1 trial -
BCA-81472709
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Cyclophosphamide
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Cyclophosphamide
Iovance Biotherapeutics B.V.
Locally Advanced Melanoma
1 trial -
Cyclophosphamide
Nektar Therapeutics UK Limited
Recurrent Diffuse Large B-Cell Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.